Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer

被引：0
|
作者：
Koichi Uemura
Yasuhide Miyoshi
Takashi Kawahara
Shuko Yoneyama
Yusuke Hattori
Jun-ichi Teranishi
Keiichi Kondo
Masatoshi Moriyama
Shigeo Takebayashi
Yumiko Yokomizo
Masahiro Yao
Hiroji Uemura
Kazumi Noguchi
机构：
[1] Yokohama City University Medical Center,Department of Urology and Renal Transplantation
[2] Yokohama Municipal Citizen’s Hospital,Department of Urology
[3] Yokohama City University Medical Center,Department of Radiology
[4] Yokohama City University Graduate School of Medicine,Department of Urology
来源：
BMC Cancer | / 16卷
关键词：
Prostate cancer; Castration-resistant; Survival prediction; Bone scan index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer
    Uemura, Koichi
    Miyoshi, Yasuhide
    Kawahara, Takashi
    Yoneyama, Shuko
    Hattori, Yusuke
    Teranishi, Jun-ichi
    Kondo, Keiichi
    Moriyama, Masatoshi
    Takebayashi, Shigeo
    Yokomizo, Yumiko
    Yao, Masahiro
    Uemura, Hiroji
    Noguchi, Kazumi
    BMC CANCER, 2016, 16
  • [2] Prognostic value of computer-aided diagnosis system for bone scan among men with docetaxel treatment for metastatic castration-resistance prostate cancer
    Uemura, K.
    Miyoshi, Y.
    Yoneyama, S.
    Hattori, Y.
    Teranishi, J. I.
    Takebayashi, S.
    Uemura, H.
    Yao, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S82 - S82
  • [3] Prognostic value of an automated bone scan index for men with metastatic castration-resistant prostate cancer treated with cabazitaxel
    Uemura, Koichi
    Miyoshi, Yasuhide
    Kawahara, Takashi
    Ryosuke, Jikuya
    Yamashita, Daisuke
    Yoneyama, Shuko
    Yokomizo, Yumiko
    Kobayashi, Kazuki
    Kishida, Takeshi
    Yao, Masahiro
    Uemura, Hiroji
    BMC CANCER, 2018, 18
  • [4] Prognostic value of an automated bone scan index for men with metastatic castration-resistant prostate cancer treated with cabazitaxel
    Koichi Uemura
    Yasuhide Miyoshi
    Takashi Kawahara
    Jikuya Ryosuke
    Daisuke Yamashita
    Shuko Yoneyama
    Yumiko Yokomizo
    Kazuki Kobayashi
    Takeshi Kishida
    Masahiro Yao
    Hiroji Uemura
    BMC Cancer, 18
  • [5] Prognostic factors in men with metastatic castration-resistant prostate cancer treated with cabazitaxel
    Belderbos, Bodine P. S.
    de Wit, Ronald
    Oomen-de Hoop, Esther
    Nieuweboer, Annemieke
    Hamberg, Paul
    van Alphen, Robbert J.
    Bergman, Andre
    van der Meer, Nelly
    Bins, Sander
    Mathijssen, Ron H. J.
    van Soest, Robert J.
    ONCOTARGET, 2017, 8 (63) : 106468 - 106474
  • [6] Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer
    Armstrong, A. J.
    George, D. J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2010, 13 (02) : 108 - 116
  • [7] Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer
    A J Armstrong
    D J George
    Prostate Cancer and Prostatic Diseases, 2010, 13 : 108 - 116
  • [8] Docetaxel in very elderly men with metastatic castration-resistant prostate cancer
    Wong, Hui-Li
    Lok, Sheau Wen
    Wong, Shirley
    Parente, Phillip
    Rosenthal, Mark
    PROSTATE INTERNATIONAL, 2015, 3 (02) : 42 - 46
  • [9] Prognostic Value of Automated Bone Scan Index in Men With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide or Abiraterone Acetate
    Miyoshi, Yasuhide
    Uemura, Koichi
    Kawahara, Takashi
    Yoneyama, Shuko
    Hattori, Yusuke
    Teranishi, Jun-ichi
    Ohta, Jun-ichi
    Takebayashi, Shigeo
    Yokomizo, Yumiko
    Hayashi, Narihiko
    Yao, Masahiro
    Uemura, Hiroji
    CLINICAL GENITOURINARY CANCER, 2017, 15 (04) : 472 - 478
  • [10] Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel
    Halabi, Susan
    Dutta, Sandipan
    Tangen, Catherine M.
    Rosenthal, Mark
    Petrylak, Daniel P.
    Thompson, Ian M., Jr.
    Chi, Kim N.
    De Bono, Johann S.
    Araujo, John C.
    Logothetis, Christopher
    Eisenberger, Mario A.
    Quinn, David, I
    Fizazi, Karim
    Morris, Michael J.
    Higano, Celestia S.
    Tannock, Ian F.
    Small, Eric J.
    Kelly, William Kevin
    JNCI CANCER SPECTRUM, 2020, 4 (02)
12345